Flint, Mike <br/><br/>
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.  [electronic resource] 

 -  Nature communications  01 2019 
 - 285 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-018-08135-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Animals<br/>Antiviral Agents--pharmacology<br/>Cathepsin B--metabolism<br/>Chlorocebus aethiops<br/>Clustered Regularly Interspaced Short Palindromic Repeats--genetics<br/>Ebolavirus--pathogenicity<br/>Fibroblasts<br/>Gene Knockout Techniques<br/>Hemorrhagic Fever, Ebola--drug therapy<br/>Humans<br/>Mucolipidoses--genetics<br/>Proprotein Convertases--antagonists & inhibitors<br/>Protease Inhibitors--pharmacology<br/>Pyrrolidines--pharmacology<br/>Serine Endopeptidases--metabolism<br/>Transferases (Other Substituted Phosphate Groups)--antagonists & inhibitors<br/>Vero Cells<br/>Virus Internalization--drug effects<br/>Whole Genome Sequencing